Introduction
============

Chronic obstructive pulmonary disease (COPD) refers to a progressive deterioration of lung function and a series of mental and physical comorbidities.[@b1-copd-13-1353] It is one of the main contributors to the global burden of disease. COPD has caused significant morbidity and mortality especially in developing countries. There are also excessive health resource consumption and health expenditures attributed to COPD worldwide. Researchers have found greater burden of COPD in China than in developed countries. In 2008, COPD was known as the fourth and third leading cause of death in urban and rural areas in China, respectively.[@b2-copd-13-1353] There is big variation in the reported prevalence of COPD among different geographic areas in China, which is partly due to different levels of exposure to risk factors and disparities in socioeconomic development among different areas.[@b3-copd-13-1353] Despite the abundant information on the epidemiological impact of COPD, there is limited evidence on its economic influence.[@b4-copd-13-1353] Hence, in-depth study on the disease burden of COPD is still an urgent need.

The aim of this systematic review was to quantify the disease burden of COPD in China and to determine the risk factors of the disease. Data on prevalence, consultation rate, risk factors, mortality, disease burden, cost of illness, and quality of life (QoL) are extracted from available studies and analyzed to improve public awareness of COPD.

Methods
=======

Literature search
-----------------

A systematic review was conducted to identify articles regarding disease burden of COPD in mainland China in both Chinese and English published before October 2015. The literature search was carried out in electronic databases such as CNKI, Wanfang Data, VIP, PubMed, Embase, and Cochrane. The search terms were as follows: "COPD", "cost", and "health care costs". With CNKI and PubMed as examples, the retrieval strategies are shown in [Box 1](#bx1-copd-13-1353){ref-type="boxed-text"}. Duplicate studies were identified and removed by using NoteExpress.

Study selection
---------------

Publications identified from the first round of search were reviewed by title and abstract independently by two investigators (BZ and YW). The inclusion and exclusion criteria used for study selection are listed in [Table 1](#t1-copd-13-1353){ref-type="table"}.

Methodological quality assessment
---------------------------------

The quality of the studies was assessed by using a self-established scale based on Agency for Healthcare Research and Quality Assessment Form,[@b5-copd-13-1353] the Newcastle--Ottawa Scale,[@b6-copd-13-1353] and Drummond Criteria[@b7-copd-13-1353] ([Table 2](#t2-copd-13-1353){ref-type="table"}). The studies were assessed independently by two reviewers (BZ and JM). The assessment scores were then confirmed and pooled together. Quality score was in the range of 0--10 points, and the articles were categorized into three classes. Articles with ≥8 points were listed under category A, 4--7 points under category B, and \<4 points under category C. This study excluded studies with poor quality, that is, those in category C.

###### Examples of retrieval strategy

CNKI retrieval strategy \#1 "Chronic Obstructive Lung" OR "Chronic Obstructive Pulmonary Disease" OR "COPD"\#2 "disease burden" OR "epidemic" OR "prevalence" OR "mortality" OR "incidence" OR "hospitalization rate" OR "economic burden" OR "cost" OR "expense" OR "disability adjusted life years" OR "disability adjusted living years" OR "DALY" OR "years lost due to disability" OR "years of life lost" OR "YLD" OR "YLL"\#3 \#1 AND \#2

PubMed retrieval strategy \#1 "China"\[Mesh\]\#2 "Pulmonary Disease, Chronic Obstructive"\[Mesh\] OR "COPD, Severe Early-Onset" \[Supplementary Concept\] "COPD/economics"\[Mesh\] OR "COPD/epidemiology"\[Mesh\] OR "COPD/mortality"\[Mesh\]\#3 "Cost of Illness"\[Mesh\]\#4 \#1 AND \#2 AND \#3

Data extraction
---------------

A standardized data extraction form was used to obtain data from research studies included in the final review, including article name, journal of publication, authors, institution of study, year of publication, study design, region of study, study duration, data source, sample characteristics (population and age), prevalence, incidence, influencing factors, consultation rate, mortality, disability-adjusted living years (DALY), years of life lost (YLL), years lost due to disability (YLD), QoL, the scale used for QoL assessment, direct medical cost (yuan per capita, per year), direct medical cost (per capita, per year) \#% of income per year, direct non-medical cost (yuan per capita, per year), direct non-medical cost (per capita, per year) \#% of income per year, indirect cost (yuan per capita, per year), indirect cost (per capita, per year) \#% of income per year, total disease cost (yuan per capita, per year), outpatient expenditure (yuan per capita, per time), hospitalization expenses (yuan per capita, per time), total disease cost of \#% total health expenditure, and main reason for cost/influence factors.

Results
=======

Literature search
-----------------

The process and results of literature screening are shown in [Figure 1](#f1-copd-13-1353){ref-type="fig"}. Of all the articles assessed by the quality assessment scale, six were recognized as low quality and excluded from the research ([Table S1](#SD1-copd-13-1353){ref-type="supplementary-material"}). The number of articles included in the review is 47: 14 in English and 33 in Chinese, with an average quality assessment score of 7.70 out of 10. The years of publication of the included studies range from 2002 to 2015. About half of the papers (24 out of 47) were published in 2011 or later. Of the 47 studies identified in the literature review, 15 are about prevalence, 14 about QoL, nine about DALY/YLL/YLD, and 18 about economic burden ([Table 3](#t3-copd-13-1353){ref-type="table"}).

Burden of disease
-----------------

### Prevalence

A total number of 13 studies are engaged in quantitative analysis of prevalence ([Table 4](#t4-copd-13-1353){ref-type="table"}). The overall prevalence of COPD in China ranges from 1.20% to 8.87%, with an average of 5.87%. The prevalence rate of COPD is significantly lower in research studies including population aged \<35 years, in consistent with the finding that the prevalence rate of COPD rises with the age of certain population segmentation.[@b44-copd-13-1353],[@b53-copd-13-1353] An overall trend is that the prevalence rate of COPD is higher among men (7.76%) in comparison with women (4.07%) and that the disease is more prevalent in rural areas (7.62%) than in urban areas (6.09%).

Another research conducted by the World Bank estimated that the number of projected cases of COPD in China would be 25,658,483 in 2010, 42,527,240 in 2020 and 55,174,104 in 2030.[@b31-copd-13-1353]

Consultation rate
-----------------

The diagnostic rate of COPD (number of patients diagnosed with COPD divided by the number of COPD cases found through epidemiology research) in China varies from 23.61% to 30.00%.[@b23-copd-13-1353],[@b37-copd-13-1353],[@b44-copd-13-1353] The percentage of COPD patients receiving outpatient treatment is around 50%,[@b50-copd-13-1353],[@b56-copd-13-1353] while the admission rate ranges between 8.78% and 35.60%[@b28-copd-13-1353],[@b50-copd-13-1353],[@b56-copd-13-1353] ([Figure 2](#f2-copd-13-1353){ref-type="fig"}). A national survey across seven provinces[@b37-copd-13-1353] found that the regular medical treatment rate of COPD patients was only 7.9% which calls for the improvement of the prevention and management of COPD. There is still a large amount of unmet needs in health services among COPD patients in China.

Risk factors of COPD
--------------------

A total of 13 studies analyzed the risk factors of COPD. [Figure 3](#f3-copd-13-1353){ref-type="fig"} shows the major factors and the number of studies that define them as risk factors of COPD in China. Tobacco exposure and biomass fuel/solid fuel usage are documented as two important risk factors of COPD, mentioned in eight (61.54%) studies[@b16-copd-13-1353],[@b23-copd-13-1353],[@b27-copd-13-1353],[@b33-copd-13-1353],[@b37-copd-13-1353],[@b48-copd-13-1353],[@b51-copd-13-1353],[@b53-copd-13-1353] and seven (53.85%) studies,[@b11-copd-13-1353],[@b27-copd-13-1353],[@b37-copd-13-1353],[@b45-copd-13-1353],[@b48-copd-13-1353],[@b52-copd-13-1353],[@b53-copd-13-1353] respectively. Other major risk factors include gender,[@b11-copd-13-1353],[@b23-copd-13-1353],[@b48-copd-13-1353],[@b53-copd-13-1353] age,[@b11-copd-13-1353],[@b23-copd-13-1353],[@b48-copd-13-1353],[@b53-copd-13-1353] low BMI,[@b15-copd-13-1353],[@b23-copd-13-1353],[@b48-copd-13-1353],[@b53-copd-13-1353] family history,[@b23-copd-13-1353],[@b27-copd-13-1353],[@b48-copd-13-1353],[@b53-copd-13-1353] history of respiratory disease,[@b11-copd-13-1353],[@b23-copd-13-1353],[@b48-copd-13-1353],[@b53-copd-13-1353] occupational dust exposure,[@b23-copd-13-1353],[@b27-copd-13-1353],[@b53-copd-13-1353] and low education level.[@b11-copd-13-1353],[@b33-copd-13-1353],[@b53-copd-13-1353]

Other risk factors include cardiovascular disease,[@b11-copd-13-1353] lack of exercise and social support,[@b27-copd-13-1353] low level of household income,[@b33-copd-13-1353] frequency of cooking,[@b48-copd-13-1353] having house remodelling in the past 5 years,[@b48-copd-13-1353] and poor ventilation in the kitchen,[@b53-copd-13-1353] which are not listed in the figure because of their low level of evidence strength; that is, they are mentioned by only one study.

Another case--control study[@b46-copd-13-1353] conducted in Xuanwei, a region with high exposure to indoor smoky coal emissions, tested the association between single-nucleotide polymorphisms and COPD risk and concluded that polymorphisms in CSF2, IL8, and PTEN may have an effect on the pathogenesis of COPD.

Mortality
---------

According to the Global Burden of Disease Study 2010,[@b8-copd-13-1353] COPD ranked among the top three leading causes of death in China, causing 934,000 deaths (534,000 men and 400,000 women) in 2010.

The age-standardized mortality rate of COPD declined from 235.2/100,000 in 1990 to 90.5/100,000 in 2010.[@b8-copd-13-1353] Another regional study reported a similar trend:[@b18-copd-13-1353] the age-standardized mortality rate of COPD in Jinshan District, Shanghai (located in eastern China) declined from 219.43/100,000 in 1985 to 45.66/100,000 in 2011, yet the level of premature mortality of COPD in China is still worse than the average outcomes of the member coutries of Group of Twenty (G20).[@b22-copd-13-1353]

Another two studies reported the level of COPD mortality in Kunming, Yunnan Province which is located in the southwest of China: the age-standardized mortality rate of COPD in 2003 was the highest in rural areas (184.4/100,000), followed by suburban (129.5/100,000), and then urban areas (51.2/100,000),[@b55-copd-13-1353] while the crude mortality rate in rural Kunming was 65.67/100,000 in 2010.[@b24-copd-13-1353]

Lin et al[@b9-copd-13-1353] suggested that \~65 million people may die from COPD from 2003 to 2033, accounting for 19% of all deaths over this period, unless the smoking rate and solid-fuel usage are controlled.

DALY
----

Combining premature mortality (YLL) and disability (YLD) together in terms of DALYs provides an overall picture of the disease burden of COPD in China. According to the Global Burden of Disease Study 2010, a total number of 16,723,800 DALYs were caused by COPD, ranking among the top 10.[@b22-copd-13-1353] The age-standardized rate of DALY declined from 4,120.1/100,000 in 1990 to 1,575.9/100,000 in 2010.[@b10-copd-13-1353] Another regional study reported that the rate of DALY in rural Kunming, Yunnan Province, was 602/100,000 (673/100,000 among men and 526/100,000 among women).[@b24-copd-13-1353]

COPD also remained one of the leading causes of YLL,[@b10-copd-13-1353] causing 12,946,000 YLL. Age-standardized YLL rates of COPD decreased from 3,756.9/100,000 in 1990 to 1,235.6/100,000 in 2010, ranked 18 in 2010 among the member countries of G20, worse than the average outcome.[@b22-copd-13-1353] In Kunming, Yunnan Province, COPD was ranked second among the causes of YLL in urban and suburban areas and ranked top in rural areas in 2003.[@b55-copd-13-1353]

In Xuzhou, Jiangsu Province, COPD caused 1.76 years of potential life lost per patient among men and 1.18 among women in 2007.[@b27-copd-13-1353] In Shanghai Jinshan District, over 27 years, from 1985 to 2011, the standardized rate of years of potential life lost decreased from 1,543/100,000 to 140/100,000.[@b18-copd-13-1353]

Cost of illness
---------------

### Total disease cost

A total of 12 studies analyzed the disease cost ([Table 5](#t5-copd-13-1353){ref-type="table"}). The direct cost of COPD ranges from 499 to 1,930 USD per capita per year. The direct medical cost of COPD ranges from 72 to 3,565 USD per capita per year, accounting for 33.33%--118.09% of local average annual income.[@b28-copd-13-1353],[@b47-copd-13-1353] The indirect cost ranges from 20 to 783 USD per capita per year, with the total disease cost being around 700--1,800 USD. The study conducted in Chengdu suggested that the direct cost of COPD accounted for 22.98% of patients' annual income, while indirect cost accounted for 4.72%.[@b17-copd-13-1353]

A human capital approach is usually adopted in calculating the indirect cost, while there is disagreement concerning the loss of working time due to COPD. A study in rural Yunnan found that COPD patients were incapable of working for about 150 days each year, while their family members were unable to work for 59 days each year;[@b28-copd-13-1353] hence, the lifetime indirect cost of COPD was 3,414 USD per capita when the method of YPLL was applied. Two other research studies brought forth similar conclusions that COPD patients were prevented from work for an average time of 17 days[@b41-copd-13-1353] and 15 days per year,[@b29-copd-13-1353] indicating high economic impact of COPD caused by loss in productivity.

In terms of lifetime indirect loss due to COPD, a multinational evaluation claimed the average losses in China to be the lowest (678 USD[@b32-copd-13-1353]) among five countries. Another research conducted in Guangzhou concluded that the lifetime loss was 7,256 USD per capita.[@b34-copd-13-1353]

Only one study reported the intangible cost of COPD: 1,168 USD per capita per year in rural Yunnan.[@b24-copd-13-1353]

Outpatient and inpatient expenditure
------------------------------------

The results of hospitalization costs of COPD vary largely among different studies. Hospital-based studies usually lead to higher hospitalization expenses, as shown in [Table 6](#t6-copd-13-1353){ref-type="table"}. Nonetheless, researchers consistently report that inpatient services account for a larger proportion of total disease suggested that costs of inpatient services accounted for 77% of COPD-related medical costs.[@b12-copd-13-1353]

### Main reason for cost

In terms of the influence factors of cost, the most frequently mentioned factors are number of visits/admissions[@b13-copd-13-1353],[@b17-copd-13-1353],[@b47-copd-13-1353],[@b49-copd-13-1353],[@b56-copd-13-1353] and severity of the disease.[@b13-copd-13-1353],[@b39-copd-13-1353],[@b49-copd-13-1353],[@b56-copd-13-1353]

Researchers found that patients with high-income levels usually generate higher medical costs and that those unemployed often bear lower economic burden. In terms of insurance type, patients with free medical services (a type of insurance for public servants where most of their medical expenditures are paid by the state) usually have higher medical costs.[@b56-copd-13-1353]

Yet contradictory perspectives on the influence of patient sources on medical costs exist. Some believe that local patients bear higher medical costs because of the relatively higher income level and sound insurance system,[@b13-copd-13-1353] while others hold the opposite view that patients from nonlocal areas have undergone heavier economic burden due to the severity of their diseases when they need to go to a major city for treatment.[@b34-copd-13-1353]

Other influencing factors include length of stay,[@b13-copd-13-1353],[@b34-copd-13-1353] age,[@b40-copd-13-1353],[@b47-copd-13-1353] status of smoking,[@b47-copd-13-1353] whether undertaking surgery,[@b34-copd-13-1353] marital state,[@b34-copd-13-1353] attitude toward the disease,[@b49-copd-13-1353] and physical exercise.[@b17-copd-13-1353]

QoL
---

A total of 13 studies are included in the analysis of scales used for QoL assessment ([Figure 4](#f4-copd-13-1353){ref-type="fig"}). The most commonly used scales include Saint George Respiratory Questionnaire,[@b20-copd-13-1353],[@b21-copd-13-1353],[@b27-copd-13-1353],[@b36-copd-13-1353],[@b41-copd-13-1353] Airways Questionnaire 20 (AQ20),[@b14-copd-13-1353],[@b25-copd-13-1353],[@b30-copd-13-1353] 12-item short-form health survey questionnaire,[@b38-copd-13-1353] Medical Coping Modes Questionnaire,[@b25-copd-13-1353] COPD Assessment Test,[@b26-copd-13-1353] EuroQol Five-Dimensional Questionnaire,[@b32-copd-13-1353] and their revised versions. One of the studies established a self-made scale to assess the QoL of COPD patients.[@b54-copd-13-1353]

An overall conclusion is that the quality assessment scores are lower among COPD patients, and four studies report significant results when compared with non-COPD patients. In two studies applying AQ20, the QoL of 56.1%--61.9% of COPD patients are in the lower and poorer level. Another two studies reported higher likelihood of COPD patients to have depression.[@b14-copd-13-1353],[@b26-copd-13-1353] The status of QoL is worse among COPD patients than in non-COPD patients, and they are at higher risk of having depression.

Conclusion
==========

The prevalence of COPD shows a wide range of variation throughout the nation. An overall trend is that the prevalence rate is higher among men and in rural areas. The diagnostic rate, outpatient treatment rate, and admission rate of COPD are relatively low, indicating considerable under-treatment and unmet medical needs of COPD in China. Tobacco exposure and biomass fuel/solid fuel usage are documented as two important risk factors of COPD. The results of economic burden of COPD vary largely due to differences in study designs and heterogeneity of sample characteristics. While various studies reported different degrees of productivity loss in both COPD patients and their relatives, there is still an urgent need to understand the overall cost of COPD in China through well-designed research on disease burden.

In view of the high smoking rate and considerable concerns related to air pollution and smog in China, as well as the large gap of unmet medical needs, countermeasures need to be taken to improve disease prevention and management to reduce disease burdens raised by COPD.

Supplementary material
======================

###### 

Quality assessment results of included studies

  No   Article title                                                                                                                                                                                          Quality scale
  ---- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------
  1    Changing pattern of premature mortality burden over 6 years of rapid growth of the economy in suburban south-west China: 1998--2003                                                                    B
  2    Rural-urban differentials of premature mortality burden in south-west China                                                                                                                            B
  3    Rapid health transition in China, 1990--2010: findings from the Global Burden of Disease study 2010                                                                                                    A
  4    NSFC health research funding and burden of disease in China                                                                                                                                            B
  5    Toward a healthy and harmonious life in China: stemming the rising tide of non-communicable diseases                                                                                                   B
  6    Vulnerability of patients with chronic obstructive pulmonary disease according to gender in China                                                                                                      B
  7    Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study                                                       B
  8    The economic burden of smoking and secondhand smoke exposure in rural South-West China                                                                                                                 B
  9    COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease \[COPD\] on a working age population                                                                    B
  10   Better understanding the influence of cigarette smoking and indoor air pollution on chronic obstructive pulmonary disease: a case-control study in Mainland China                                      A
  11   Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China                                                                                              A
  12   A report of cytokine polymorphisms and COPD risk in Xuan Wei, China                                                                                                                                    B
  13   PTEN identified as important risk factor of chronic obstructive pulmonary disease                                                                                                                      B
  14   Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study                                                             A
  15   Prevalence of chronic obstructive pulmonary disease in Ningxia Province of China (in Chinese)                                                                                                          B
  16   The economic burden of chronic obstructive pulmonary disease (COPD) in Shanghai and the feasibility of 3D reconstruction using low-dose CT scan in diagnosis and classification of COPD (in Chinese)   B
  17   The study of the economic burden on Chinese rural COPD patients (in Chinese)                                                                                                                           B
  18   A study on economic burden for hospitalized patients with COPD (in Chinese)                                                                                                                            B
  19   The risk factors of chronic obstructive pulmonary disease in Heilongjiang province (in Chinese)                                                                                                        B
  20   Study on the prevalence rate and risk factors of chronic obstructive pulmonary disease in rural community population in Hubei province (in Chinese)                                                    B
  21   Correlation study of body mass index with morbidity rate of chronic obstructive pulmonary disease in parts of Xinjiang (in Chinese)                                                                    B
  22   Analysis on status of chronic obstructive pulmonary disease in rural population (in Chinese)                                                                                                           B
  23   Analysis on economic burden of COPD patients in Tongshan County (in Chinese)                                                                                                                           B
  24   Direct economic burden of 803 patients with chronic obstructive pulmonary disease and influencing factors in Ningbo (in Chinese)                                                                       B
  25   The disease burden of chronic obstructive pulmonary disease among people aged over 15 years in 1990 and 2010 in China (in Chinese)                                                                     A
  26   Analysis on direct economic burden of hospitalized patients with COPD and its influencing factors in a three-level hospital in Beijing (in Chinese)                                                    B
  27   Analysis on direct economic burden of community COPD patients and its influence factors in Chengdu (in Chinese)                                                                                        B
  28   Research on direct economic burden of chronic obstructive pulmonary disease in community of Xuzhou City (in Chinese)                                                                                   B
  29   Current status of prevention and management of chronic obstructive pulmonary disease in rural area in China (in Chinese)                                                                               A
  30   Impact of chronic obstructive pulmonary disease on quality of life and economic burden in Chinese urban areas (in Chinese)                                                                             B
  31   Costs of the last hospitalization for patients with acute exacerbation of chronic obstructive pulmonary disease and patients with lung cancer (in Chinese)                                             B
  32   The economic burden of the COPD and its factor analysis (in Chinese)                                                                                                                                   B
  33   Analysis of prevalence and economic burden of chronic obstructive pulmonary disease in rural residents of Yunnan Province (in Chinese)                                                                 B
  34   Economic burden and influence factors of chronic obstructive pulmonary disease patients in Chenghua District (in Chinese)                                                                              B
  35   Mortality and the trend of YPLL of COPD in Jinshan District of Shanghai City from 1985--2011 (in Chinese)                                                                                              B
  36   Factors influencing the use of health care services from patients with COPD in Chengdu (in Chinese)                                                                                                    B
  37   Study on the costs of chronic obstructive pulmonary disease (in Chinese)                                                                                                                               B
  38   The correlational study of severity and QoL of stable phase chronic obstructive pulmonary disease patients (in Chinese)                                                                                B
  39   Analysis on quality of life and its influencing factors in patients with stable chronic obstructive pulmonary disease (in Chinese)                                                                     B
  40   Analysis on quality of life of patients with chronic obstructive pulmonary disease and its influencing factors (in Chinese)                                                                            B
  41   Investigation and analysis on the quality of life and influence factors in patients with COPD (in Chinese)                                                                                             B
  42   Quality of life and coping style in patients with chronic obstructive pulmonary disease (in Chinese)                                                                                                   B
  43   Evaluation and analysis on quality of life and influencing factors of patients with chronic obstructive pulmonary disease (in Chinese)                                                                 B
  44   Quality of life and its related factors in patients of stable chronic obstructive pulmonary disease (in Chinese)                                                                                       B
  45   Survey of the quality of life and social supports of patients with chronic obstructive pulmonary disease in community (in Chinese)                                                                     B
  46   Application of COPD-specific version of the St George's Respiratory Questionnaire in evaluating quality of life among COPD patients in Guangzhou (in Chinese)                                          B
  47   The quality of life of patients with chronic obstructive pulmonary disease and correlated factors (in Chinese)                                                                                         A

The abstract of this work was submitted to International Society for Pharmacoeconomics and Outcomes Research 21st Annual International Meeting as a poster presentation and was published in *Value in Health* in 2016.
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###### 

Inclusion and exclusion criteria

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Inclusion criteria                                                      Exclusion criteria
  ----------------------------------------------------------------------- -----------------------------------------------------------------------------------------
  • Chinese or English language\                                          • Conference abstracts, case reports, letters, comments, editorials, and review papers\
  Full-text available\                                                    • Economic evaluation studies on therapies\
  • Studies that consider the disease burden or quality of life of COPD   • Epidemiological studies on pathogenesis or etiology\
                                                                          • Intervention studies\
                                                                          • Clinical studies\
                                                                          • Effect studies\
                                                                          • Animal or in vitro studies

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Quality assessment scale

  --------------------------------------------------
  1\. Was the objective clear?
  2\. Was the data source official?
  3\. Was the study population-based?
  4\. Was the sampling randomized?
  5\. Was the study region nationwide?
  6\. Were the diagnostic criteria clear?
  7\. Were the results comparatively analyzed?
  8\. Did outcome indicators include DALY/YLL/YLD?
  9\. Can the results be externalized?
  --------------------------------------------------

**Notes:** All items have two possible answers except number 9: yes (+) and no (−). Item 9 has three possible responses: yes (++), likely (+), and no (−).

**Abbreviations:** DALY, disability-adjusted living year; YLL, years of life lost; YLD, years lost due to disability.

###### 

Characteristics of included studies (n=47)

  Study                                         Publication year   Region of study                          Data source           Sample size   Sample age (years)   Indicator of disease burden                               Language
  --------------------------------------------- ------------------ ---------------------------------------- --------------------- ------------- -------------------- --------------------------------------------------------- ----------
  Yin et al[@b10-copd-13-1353]                  2015               China                                    Official statistics                 \>15                 Prevalence, mortality, DALY, YLL, YLD                     Chinese
  Han et al[@b11-copd-13-1353]                  2015               Heilongjiang                             Survey                4,478         \>40                 Prevalence, influencing factors                           Chinese
  Shi et al[@b12-copd-13-1353]                  2015               Ningbo, Zhejiang                         Institutional data    803           \>60                 Direct cost                                               Chinese
  Huang[@b13-copd-13-1353]                      2015               Beijing                                  Institutional data    1,638         73.4±9.07            Direct cost                                               Chinese
  Chen and Bian[@b14-copd-13-1353]              2015               Zhuji, Zhejiang                          Survey                82            36--81               QoL                                                       Chinese
  Zhu et al[@b15-copd-13-1353]                  2014               Xinjiang                                 Survey                2,874         \>35                 Prevalence, influencing factors                           Chinese
  Cai et al[@b16-copd-13-1353]                  2014               Yunnan Province                          Survey                17,158        \>18                 Prevalence, influencing factors, direct & indirect cost   English
  Xu et al[@b17-copd-13-1353]                   2013               Chengdu, Sichuan                         Survey                83            54--86               Direct & indirect cost                                    Chinese
  Zhu et al[@b18-copd-13-1353]                  2013               Jinshan, Shanghai                        Institutional data                                       Mortality, YLL                                            Chinese
  An et al[@b19-copd-13-1353]                   2013               Beijing                                  Survey                97                                 QoL                                                       Chinese
  Fang et al[@b20-copd-13-1353]                 2013               Shanghai                                 Survey                101           76.15                QoL                                                       Chinese
  Jiang[@b21-copd-13-1353]                      2013               Guangzhou, Guangdong                     Survey                278           67.6±8.0             QoL                                                       Chinese
  Yang et al[@b22-copd-13-1353]                 2013               China                                    GBD2010                                                  Mortality, DALY, YLL, YLD                                 English
  Qiu[@b23-copd-13-1353]                        2012               Ningxia                                  Survey                4,626         \>40                 Prevalence, influencing factors, consultation rate        Chinese
  Mao et al[@b24-copd-13-1353]                  2012               Yunnan (rural)                           Survey                9,396         ≥18                  Prevalence, mortality, DALY, direct & indirect cost       Chinese
  Li[@b25-copd-13-1353]                         2008               Guangzhou, Guangdong                     Survey                102           38--83               QoL                                                       Chinese
  He et al[@b26-copd-13-1353]                   2012               Huaian, Jiangsu                          Survey                185           ≥60                  QoL                                                       Chinese
  Lou et al[@b27-copd-13-1353]                  2012               Xuzhou, Jiangsu                          Survey                5,900         40--75               Influencing factors, YLL, QoL, direct & indirect cost     English
  Lou et al[@b28-copd-13-1353]                  2012               Xuzhou, Jiangsu                          Survey                8,217         36--84               Consultation rate, YLL, direct & indirect cost            English
  Xu et al[@b29-copd-13-1353]                   2011               China                                    Survey                1,859         \>18                 Prevalence, direct & indirect cost                        Chinese
  Liu et al[@b30-copd-13-1353]                  2011               Meizhou, Guangdong                       Survey                134           58--85               QoL                                                       Chinese
  Wang et al[@b31-copd-13-1353]                 2011               China                                    Official statistics                 ≥40                  Prevalence, mortality                                     English
  Fletcher et al[@b32-copd-13-1353]             2011               Brazil, China, Germany, Turkey, UK, US   Survey                2,426         45--67               QoL, direct & indirect cost                               English
  Yin et al[@b33-copd-13-1353]                  2011               China                                    Official statistics   49,363        15--69               Prevalence, influencing factors                           English
  Guo[@b34-copd-13-1353]                        2010               Guangzhou, Guangdong                     Institutional data    669                                Direct & indirect cost                                    Chinese
  Lou et al[@b35-copd-13-1353]                  2010               Xuzhou, Jiangsu                          Survey                383           34--84               YLL, direct & indirect cost                               Chinese
  Lu and Li[@b36-copd-13-1353]                  2010               Beijing                                  Survey                61                                 QoL                                                       Chinese
  Zhou et al[@b37-copd-13-1353]                 2009               China (rural)                            Survey                11,290        ≥40                  Prevalence, influencing factors, consultation rate, QoL   Chinese
  Zhou et al[@b38-copd-13-1353]                 2009               China                                    Survey                20,245        ≥40                  QoL                                                       Chinese
  Chen[@b39-copd-13-1353]                       2009               Shanghai                                 Institutional data    83            \>40                 Direct cost                                               Chinese
  An et al[@b40-copd-13-1353]                   2009               Xuzhou, Jiangsu                          Survey                383           62                   Direct cost                                               Chinese
  He et al[@b41-copd-13-1353]                   2009               China                                    Survey                723           67±10                QoL, direct & indirect cost                               Chinese
  Zhu and Cai[@b42-copd-13-1353]                2009               Beijing                                  Institutional data    416                                Direct cost                                               Chinese
  Hosgood et al[@b43-copd-13-1353]              2009               Xuan Wei, Yunnan                         Survey                160                                Influencing factors                                       English
  Jiang et al[@b44-copd-13-1353]                2008               Hubei                                    Survey                1,883         \>40                 Prevalence, consultation rate                             Chinese
  Cai et al[@b45-copd-13-1353]                  2008               Kunming, Yunnan (Suburban)               Official statistics   335,622       \>0                  Influencing factors, mortality, YLL                       English
  Shen et al[@b46-copd-13-1353]                 2008               Xuan Wei, Yunnan                         Survey                178                                Influencing factors                                       English
  Zhang[@b47-copd-13-1353]                      2007               Shandong                                 Survey                                                   Direct & indirect cost                                    Chinese
  Jiang et al[@b48-copd-13-1353]                2007               Hubei                                    Survey                1,883         \>40                 Prevalence, influencing factors                           Chinese
  Zhang et al[@b49-copd-13-1353]                2007               Chengdu, Sichuan                         Survey                446                                Direct cost                                               Chinese
  Zhang et al[@b50-copd-13-1353]                2007               Chengdu, Sichuan                         Survey                446           38--94               Consultation rate                                         Chinese
  Xu et al[@b51-copd-13-1353]                   2007               Nanjing                                  Survey                29,319        ≥35                  Prevalence, influencing factors                           English
  Liu et al[@b52-copd-13-1353]                  2007               Guangdong                                Survey                3,286         ≥40                  Prevalence, influencing factors                           English
  Zhong et al[@b53-copd-13-1353]                2007               China                                    Survey                20,245        40--99               Prevalence, influencing factors                           English
  Yang et al[@b54-copd-13-1353]                 2006               Beijing                                  Survey                110           68--90               QoL                                                       Chinese
  Cai and Chongsuvivatwong[@b55-copd-13-1353]   2006               Kunming, Yunnan                          Official statistics   894,253       \>0                  Mortality, YLL                                            English
  Ren et al[@b56-copd-13-1353]                  2002               Chengdu, Sichuan                         Survey                205                                Consultation rate, direct cost                            Chinese

**Abbreviations:** DALY, disability-adjusted living years; YLL, years of life lost; YLD, years lost due to disability; QoL, quality of life.

###### 

Prevalence of COPD in China

  Publication year   Study region                      Sample size   Age (years)   Prevalence (%)                         
  ------------------ --------------------------------- ------------- ------------- ---------------- ------ ------- ------ ------
  2015               China[@b10-copd-13-1353]                        \>15          3.90                                   
  2015               Heilongjiang[@b11-copd-13-1353]   4,478         ≥40           7.30             6.50   8.60    6.00   8.80
  2014               Xinjiang[@b15-copd-13-1353]       2,874         ≥35                                                  7.50
  2014               Yunnan[@b16-copd-13-1353]         17,158        \>18          1.20             1.00   1.40           
  2012               Ningxia[@b23-copd-13-1353]        4,626         ≥40           8.87             5.35   13.01   7.97   9.78
  2012               Yunnan[@b24-copd-13-1353]         9,396         ≥18                                                  1.41
  2011               China[@b29-copd-13-1353]          1,859         ≥18                                           1.92   
  2011               China[@b33-copd-13-1353]          49,363        15--69        2.20             2.40   3.40    2.50   3.10
  2009               China[@b37-copd-13-1353]          11,290        ≥40                                                  8.80
  2007               Hubei[@b48-copd-13-1353]          1,883         ≥40                                                  9.88
  2007               Nanjing[@b51-copd-13-1353]        29,319        ≥35           5.90                                   
  2007               Guangdong[@b52-copd-13-1353]      3,286         \>40          9.40                                   
  2007               China[@b53-copd-13-1353]          20,245        40--99        8.20             5.10   12.40   7.80   8.80

###### 

Total disease cost of COPD in China[\*](#tfn4-copd-13-1353){ref-type="table-fn"}

  Publication year   Study region                      Sample size   Direct cost (per capita per year, USD)   Direct medical cost (per capita per year, USD)   Direct non-medical cost (per capita per year, USD)   Indirect cost (per capita per year, USD)   Total disease cost (per capita per year, USD)
  ------------------ --------------------------------- ------------- ---------------------------------------- ------------------------------------------------ ---------------------------------------------------- ------------------------------------------ -----------------------------------------------
  2015               Ningbo[@b12-copd-13-1353]         803                                                                                                                                                                                                     685
  2013               Chengdu[@b17-copd-13-1353]        83            1,930                                                                                                                                          396                                        
  2012               Rural Yunnan[@b24-copd-13-1353]   9,396         884                                                                                                                                            20                                         
  2011               China[@b29-copd-13-1353]          1,859         726                                                                                                                                            306                                        1,033
  2010               Xuzhou[@b28-copd-13-1353]         383                                                    298                                                                                                                                              
  2009               Shanghai[@b39-copd-13-1353]       83                                                     1,323                                                                                                                                            
  2009               China[@b41-copd-13-1353]          723                                                    3,565                                            477                                                                                             
  2007               Shandong[@b47-copd-13-1353]       150                                                    358                                              136                                                  783                                        1,277
  2007               Chengdu[@b49-copd-13-1353]        446           499                                                                                                                                                                                       
  2002               Chengdu[@b56-copd-13-1353]        205                                                    729                                                                                                                                              
  2014               Yunnan[@b16-copd-13-1353]         17,158                                                 1,657                                            109                                                  22                                         1,787
  2011               Shanghai[@b32-copd-13-1353]       398                                                    72                                                                                                    77                                         

**Notes:**

All Chinese currency in the tables of this section are adjusted to comparable prices to 2013, according to the Residence Consumption Index (<http://data.stats.gov.cn/easyquery.htm?cnC01>) and converted to USD according to the exchange rate in 2013 (6.1932 RMB=1 USD).

###### 

Outpatient and hospitalization expenditure of COPD in China

  Publication year   Study region                      Sample size   Outpatient expenditure (per capita per year) (USD)   Hospitalization expenses (per capita per year) (USD)   Features
  ------------------ --------------------------------- ------------- ---------------------------------------------------- ------------------------------------------------------ -----------------
  2015               Beijing[@b13-copd-13-1353]        1,638                                                              4,220                                                  Hospital based
  2010               Guangzhou[@b34-copd-13-1353]      669                                                                5,611                                                  Hospital based
  2009               Beijing[@b42-copd-13-1353]        416                                                                20,295                                                 Hospital based
  2002               Chengdu[@b56-copd-13-1353]        205           202                                                  338                                                    Community based
  2014               Rural Yunnan[@b16-copd-13-1353]   17,158        74                                                   1,332                                                  Community based
